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Edited by Hans EklundAbstract Mycobacterium tuberculosis contains multiple ver-
sions of the accA and accD genes that encode the a- and b-sub-
units of at least three distinct multi-functional acyl-CoA
carboxylase complexes. Because of its proposed involvement in
pathogenic M. tuberculosis survival, the high-resolution crystal
structure of the b-subunit gene accD5 product has been deter-
mined and reveals a hexameric 356 kDa complex. Analysis of
the active site properties of AccD5 and homology models of
the other ﬁve M. tuberculosis AccD homologues reveals unex-
pected diﬀerences in their surface composition, providing a
molecular rational key for a sorting mechanism governing cor-
rect acyl-CoA carboxylase holo complex assembly in M. tuber-
culosis.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Mycobaceterium tuberculosis1. Introduction
Mycobacteria contain representatives of every known lipid
biosynthetic system, including enzymes usually found in mam-
mals and plants as well as other bacterial species [1]. The gen-
ome of Mycobacterium tuberculosis, for instance, encodes
about 250 enzymes involved in fatty acid metabolism, while,
E. coli, which comprises a genome of similar size, only encodes
about 50 such enzymes [1]. Acyl-CoA carboxylases (ACCase)
are responsible for the carboxylation of acyl-CoA substrates,
thereby producing the key extender subunits for the biosynthe-
sis of fatty acids and polyketide natural products [2,3]. While
in mammals, yeast and most eukaryotic organisms, ACCase
comprises of a single polypeptide that contains all three func-
tional domains, in E. coli, for example, four individual proteins
assemble in vivo to form an active complex. The Mtb genome
encodes a total of six accD genes (accD1–6) and three accA
genes (accA1–3) [1]. Comparative genomic analyses and over-Abbreviations: ACCase, acyl-CoA carboxylase; ACC, acetyl-CoA
transferase; BCCP, biotin carrier protein; BC, biotin carboxylase;
CT, carboxytransferase; PccB, propionyl-CoA carboxytransferase
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doi:10.1016/j.febslet.2006.11.054expression and genetic deletion studies in Corynebacteriae glu-
tamicum, a commonly used Mtb model system, have identiﬁed
the b-subunits AccD4 and AccD5 as essential proteins for
mycobacterial survival due to their roles in mycolic acid for-
mation [4]. Quantitative RT-PCR analysis reveals that tran-
scription of the gene Rv3280, coding for one of six acyl-coA
carboxytransferases, AccD5, is strongly upregulated in Mtb
grown in interferon-c activated macrophages versus Mtb
grown in non-activated macrophages [5]. Given that the unique,
multiple occurrence of ACCase components, probably associ-
ated with diﬀerential substrate speciﬁcities, could reﬂect the pe-
culiar requirements for the robust cell wall of the Mtb, we
hypothesize that upregulation of AccD5 under conditions that
are eventually lethal for Mtb could be part of a self-protection
mechanism to a hostile, phagolysosomal environment. This
assumption is further supported by the failure to isolate any
accD5 Mtb knock-out mutants, despite several attempts, indi-
cating that AccD5 activity is essential to Mtb survival (Arndt
and Nasser Eddine et al., unpublished). For this contribution,
the accD5 gene product was selected for investigation due to
the marked expression changes observed when Mtb is grown
in interferon-c activated macrophages [5].2. Materials and methods
2.1. Sample preparation
AccD5 was cloned from H37Rv genomic DNA into the expression
vector pETM-11. Optimal recombinant expression was observed in
Bl21(DE3)pLysS cells following overnight auto-induction at 18 C
[6]. Cell pellets were resuspended in 50 mM HEPES, pH 8.0,
300 mM NaCl, 20 mM imidazole, 0.02% monothiolglycerol (MTG)
and lysed by freeze–thawing, DNaseI treatment and sonication. AccD5
was puriﬁed from the soluble cellular fraction by Ni-NTA aﬃnity
chromatography, followed by cleavage of the hexahistidine tag by
digestion with TEV protease and a ﬁnal size-exclusion chromatogra-
phy step (Pharmacia Superdex200 HiLoad 26/60 pre-equilibrated in
40 mM HEPES, pH 8.0, 40 mM NaCl, 0.02% MTG). Apo AccD5
crystals were grown at 22 C using the hanging-drop method by mixing
equal volumes of AccD5 (16 mg/ml) and well solution (0.5 M sodium
dihydrogen phosphate 0.1 M dipotassium hydrogen phosphate).2.2. X-ray structure determination of Mtb AccD5
Prior to data collection at 100 K, AccD5 crystals were cryo-pro-
tected in mother liquor containing 30% glycerol. Data were collected
using an ADSC Quantum-4 CCD detector at beamline BM14 at the
European Synchrotron Radiation Facility. Data were reduced using
the programs MOSFLM and SCALA [7]. Reﬂections ﬂagged for
cross-validation of the model during reﬁnement were chosen in thin-
resolution shells using the program SFTOOLS on account of the highblished by Elsevier B.V. All rights reserved.
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was solved by molecular replacement using the program Phaser [8].
The structure of propionyl-CoA carboxytransferase (PccB), modiﬁed
to create an AccD5-PccB hybrid structure by trimming back to Cb res-
idues not conserved between the two proteins, was used as the search
model. The molecular replacement solution was manually rebuilt using
the program Coot [9] alternating with reﬁnement using the programTable 1
Crystallographic statistics
X-ray data collection
Cell dimensions (A˚) 174 · 174 · 340
Space group P41212
Resolution range (A˚) 35–2.20 (2.32–2.20)
Observations (overall, unique) 1205689, 251667
Completeness (%) 98.4 (92.7)
Rsym (%) 8.4 (30.5)
Mean I/r(I) 7.6 (2.5)
X-ray structure reﬁnement
Protein residues Chain A: 21–473, 484–534, 541–548
Chain B: 21–470, 489–524, 541–548
Chain C: 21–471, 488–534, 541–548
Chain D: 21–473, 488–534, 541–548
Chain E: 21–471, 488–534, 541–548
Chain F: 21–470, 488–534, 541–548
Other atoms 1983 Water molecules
3 Glycerol molecules
Rconv, Rfree 18.5, 22.2
Mean protein temperature
factors (A˚)2
Main chain atoms: 23.5
Side chain atoms: 25.1
Other atoms: 23.7
Fig. 1. High-resolution structure of AccD5. (A) Secondary structural represen
to position: red (N-terminus) through yellow to green (C-terminus). Speciﬁc
annotation of secondary structural elements is shown in Supplementary Fig
upper panel a three-fold rotation axis extends out of the face of the pa
perpendicular two-fold axis relates the upper trimer of AccD5 molecules (co
(colored blue, magenta and green), for which the molecular surfaces are also s
program Aesop (Prof. M. Noble, unpublished).REFMAC5 [7]. As Rconv and Rfree were reduced, NCS restraints were
relaxed and B-factors were reﬁned isotropically. The structure was
solvated using the program ARP [7]. Statistics for the ﬁnal model
are given in Table 1. Coordinates and structure factors have been sub-
mitted to the PDB database with the accession code 2BZR.
2.3. Template-target sequence alignment and 3D modeling of Mtb
AccDs
The X-ray crystal structures of AccD5, S. coelicolor PccB, and the P.
shermanii 12S were used as template structures for the modeling of
AccD1-4/6 (Accession Nos. Rv2502c, Rv0974c, Rv0904c, Rv3799c,
and Rv2247, respectively) [10,11]. The 3D models of these AccD
homologues were generated by extracting pairwise alignments between
each target sequence and the template structures using the Modeller
8.1 package [12]. Twenty models were produced for each sequence
and the model with the lowest ‘‘objective function’’ was chosen. The
stereochemical quality of each model was conﬁrmed using Procheck
[13]. Side-chain conformations were reﬁned separately using the pro-
gram SCWRL3.0 [14] to yield the ﬁnal models.3. Results and discussion
3.1. The hexameric assembly of Mtb AccD5
We have solved the X-ray crystal structure of fulllength
AccD5 at a resolution of 2.2 A˚ (Fig. 1). Since during the prep-
aration of this manuscript, a lower resolution (2.9 A˚) crystal
structure of AccD5 was published [15], we summarize the over-
all structural ﬁndings only in brief and focus on our novel ﬁnd-
ings emerging from a comparison with related PccB subunits
and with a set of six diﬀerent AccD b-subunits, which aretation of the AccD5 monomer fold. The structure is colored according
secondary structural elements referred to in the text are labeled. Full
ure 1. (B) Orthogonal views of the AccD5 hexameric assembly. In the
ge, passing through the central pore of the hexameric assembly. A
lored red, orange and yellow) to the lower trimer of AccD5 molecules
hown. This ﬁgure and all other structural ﬁgures were created using the
6900 S.J. Holton et al. / FEBS Letters 580 (2006) 6898–6902uniquely found in the M. tuberculosis genome. The overall
AccD5 structure consists of a 356 kDa homo-hexameric com-
plex, consistent with evidence from static light scattering solu-
tion studies (data not shown). The complex is approximately
140 A˚ in its largest dimension, with a central pore of about
20 A˚ in diameter. Each monomer within the hexamer packs
head-to-tail with a second copy to create a dimeric assembly
that is essential for the formation of the carboxytransferase
(CT) active site. Less extensive contacts are made between
three dimers to create the full hexameric assembly. The hexa-
mer exhibits 32-symmetry whereby a three-fold axis is formed
around the center of the complex, passing through the central
pore, while a two-fold axis is observed between each of the
trimeric assemblies that stack upon each other.
The high resolution of our AccD5 structure provides an
accurate molecular description of the protein, particularly in
the correct assignment of rotamer conformations. This infor-
mation will be essential in future structure-led AccD5 inhibitor
design and optimization, for example in the characterization of
the binding nature of NCI-65828, a recently reported AccD5
inhibitor [15]. Furthermore, our comparison of the active sites
of AccD5 and S. coelicolor PccB [10] revealed that the dimen-
sions of the AccD5 active site are substantially larger, as a re-
sult of the altered location of helix Na2 (Fig. 2). In AccD5, this
helix is positioned further away from the center of the active
site by a translation of about 3.3 A˚, increasing the diameter
of the broad active site cleft by approximately 15%. This diﬀer-
ence is independent of lattice contacts, as revealed by the same
structure in a diﬀerent crystal form (Holton et al., unpub-Fig. 2. AccD5 contains an enlarged active site. (A) Superposition of
secondary structural elements in the region of the active site. AccD5 is
rendered in orange/blue (diﬀerent molecules) and PccB in gray. For
orientation the propionyl-CoA ligand from the PccB structure is also
drawn [10]. (B) The eﬀect of the change in orientation of helix Na2 on
the active site volume is seen in the surface representations of the same
structures in panel B. In these panel helix Na2 is colored in red, whilst
the remainder of the molecular surface is colored orange and gray, for
AccD5 and PccB, respectively.lished). Thus, the structure of AccD5 indicates that binding
of much larger substrates, such as longer chain fatty acids,
may be accommodated, in contrast to the narrower active site
cleft of PccB. We have also soaked a range of fatty acid-CoA
derivatives into Mtb AccD5 crystals. Although we have been
able to detect unbiased diﬀerence electron density above a
3r threshold within the expected binding site its overall quality
was not suﬃcient to unambiguously model the substrate (data
not shown). However, this ﬁnding has allowed us to conﬁrm
the correct location of the active site experimentally. Residues
within the acyl-CoA binding site, which by analogy to the
PccB-propionyl-CoA structure are predicted to form key stabi-
lizing interactions with the acyl, pantothene and ribose groups,
are highly conserved in both AccD5 and other Mtb ACCases
[10] (Supplementary Figure 1). This suggests that for these
regions of the substrate the acyl-CoA binding mode will be
conserved. In contrast, Asn80, Arg456 and Arg457 (PccB
numbering), three charged residues that stabilize the co-
enzyme-A phosphate groups in the PccB-propionyl-CoA
structure, are only partially conserved in AccD5 and other Mtb
AccDs (Supplementary Figure 1). For example, in AccD5
these residues are respectively Lys, Arg and Gln. Whilst these
side chains may also contribute positively charged surfaces to
anchor the phosphates, their diﬀering sizes hint at subtle diﬀer-
ences in the recognition and stabilization of this region of the
AccD5 substrate.3.2. Structure-derived categorization of AccD1-AccD6 in Mtb
To investigate the molecular basis of the requirement for
multiple AccD ACCase subunits in Mtb, we have built homol-
ogy models of the other ﬁve accD gene products (AccD1–4 and
AccD6). While the sequence similarity varies between the
AccD sequences (Supplementary Figure 1), we have noticed
a high amount of conservation of residues speciﬁcally involved
in (a) the hydrophobic core, and (b) intermolecular contacts,
both at the levels of inter-dimer and inter-trimer interactions.
These ﬁndings support their identiﬁcation as CTs, and further-
more, suggests that all AccD members adopt a hexameric
assembly. This is consistent with the observation that none
of the Mtb AccD sequences contains the additional C-terminal
helical insertions that are found in the yeast-CT structure,
which probably precludes a hexameric assembly [3].
Comparison of the AccD sequences and homology models
highlights a number of features that we propose to be critical
in determining the identity of both ACCase substrates and
binding partners. Considering the overall hexameric structure,
there is a striking diﬀerence in the electrostatic surface potential
between the AccD homologues (Fig. 3). Interestingly, the
AccD5 hexamer shows the most negative overall surface poten-
tial. Inspection of the models allows the generation of a series,
ranging from negative to positive surface potentials: AccD5 >
AccD4 > AccD6 > AccD2 > (AccD1, AccD3) (Fig. 3). The
highly polarized nature of this surface charge distribution
suggests that electrostatic attractive forces are key in selecting
and maintaining interactions between the ACCase compo-
nents. Therefore, diﬀerences in the magnitude of AccD surface
electronegativity suggest a simple, yet sensitive mechanism that
determines which a–b complexes will form in vivo. Those
b-subunits with similarly electronegative surfaces, for example
AccD4 and AccD5, are therefore likely to share the same cog-
nate a-subunits, while our models predict an incompatibility of
Fig. 3. Structure-based categorization of ACCase b-subunits from M. tuberculosis. (A) Superposition of AccD homology models. Superposition of
secondary structural representations of the Mtb AccD models. Only the monomeric folds of AccD2 (blue) and AccD4 (magenta) are shown for
clarity. Both structures are superimposed on the crystal structure of AccD5 (gray). (B) Comparative electrostatic character of Mtb AccDs. The
surfaces for each of the AccD homology models are rendered according to relative electrostatic charge (red through white to blue), calculated using
the program GRASP [17]. All surfaces are colored on the same arbitrary scale.
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AccD1/AccD3. Indeed, our prediction is supported by recent
co-immunoprecipitation experiments that have identiﬁed an
AccA3/AccD4/AccD5 complex. Interestingly, genetic evidence
suggests that the AccD4 and AccD5 Mtb paralogues are func-
tionally related [4]. Signiﬁcant electrostatic diﬀerences are also
observed between the AccB, PccB, and 12S structures, suggest-
ing that this is a well-conserved determinant in ACCase com-
plex formation [10]. Encouraged by these observations we
have begun a more extensive characterization of which alpha
and beta subunits assemble to form ACCase holo-complexes.
Interestingly, we have observed the in vitro formation of a sta-
ble AccA1 (Rv2501c) and AccD1 (Rv2502c) complex (S. King-
Scott, unpublished). Furthermore, this complex forms in the
absence of PccE (Rv3281), the ACCase epsilon subunit. This
is unlike the S. coelicolor ACCase complex, where AccE is
essential for the interaction between AccB and AccA2 [16],
and suggests a further level of complexity to the assembly
and regulation of ACCase activity in Mtb. In summary, using
our model and experimental data, we propose a peculiar system
governing proper ACCase complex formation in Mtb, by ‘mix
and match’ regulation of ACCase a- and b-subunit compo-
nents. The signiﬁcant diﬀerences in surface electrostatics ob-
served between molecular models of the AccD homologues
suggests that the correct formation of a/b complexes is central
for the cellular functionality of diﬀerent ACCase complexes.
However, the precise roles played by the broad range of Mtb
ACCase holo-complexes still remains unknown. Nevertheless,
our ﬁndings on the speciﬁc structural diﬀerences in the six
Mtb AccD gene products provide an opportunity for the devel-
opment of novel anti-tuberculosis drugs that may take advan-
tage of their distinct substrate requirements.
In a further step, we examined the structural models for po-
tential diﬀerences in substrate requirements, using our compar-
ative data on the experimental structures of AccD5 from Mtb
and PccB from S. coelicolor as reference. We focused in partic-
ular on the presence and location of helix Na2, as a key deter-
minant of the AccD active site dimensions. Sequence analysis
of the AccD homologues reveals that in both AccD3 and
AccD6, it is not possible to conﬁdently model helices Na1and Na2 due to the almost complete absence of sequence
homology with the template structures. However, both se-
quences are N-terminally truncated compared to the other
AccD sequences, and combined with the divergent sequences
in this region, this suggests that their structures will diﬀer in
this functionally important region. In contrast, in all other
AccD homologue models helix Na2 is predicted to be in a sim-
ilar location to that observed in the PccB structure. Whilst the
sequence homology in these models is suﬃcient to be conﬁdent
in the quality of our modeling, the sequence identity is lower
than other regions of the active site (Supplementary Figure
1). Comparison of the active site secondary structural elements
also predicts signiﬁcant diﬀerences in the locations of helices
Ca7 and Ca8, and the loop connecting them. These helices
form the center of the proposed binding site for the biotin car-
rier protein (BCCP) domain of the AccA2 subunit [10].
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